Latest News

Models help scientists understand how cancer develops - but researchers haven't had one for most ovarian cancers.

Diagnosed with breast cancer at only 27, Kelsey Harrison is now raising money to go toward cancer research.

Allison Hopkins Prey was overwhelmed by the support she received during breast cancer treatment – and happy to now say, two years later, it feels so long ago.

Dermatologist Graciela De Jesus, M.D., works with Hollings Hereditary Cancer Clinic patients at risk of melanoma and skin cancer.

MUSC Hollings researchers find that targeting an immunosuppressive protein on two fronts can reduce metastasis and restore sensitivity to immunotherapy.

An MUSC children’s cancer specialist and other experts from across state find 11% improvement in childhood cancer survival over 25-year period.

A newly approved targeted therapy for small cell lung cancer is at the forefront of a new type of drug for solid tumors.

Hollings was part of an international clinical trial that led to the FDA approval of a new drug to treat certain types of gliomas.

Two Hollings researchers are working together to develop a new way to get depression treatment to people with likely incurable cancer.

A new study aims to get a better understanding of what dual use of vapes and cigarettes looks like in real world usage.